Literature DB >> 9559471

Relationship between intraocular lens biomaterials and posterior capsule opacification.

P G Ursell1, D J Spalton, M V Pande, E J Hollick, S Barman, J Boyce, K Tilling.   

Abstract

PURPOSE: To determine whether posterior capsule opacification (PCO) is influenced by intraocular lens (IOL) material.
SETTING: A British teaching hospital eye department.
METHODS: Ninety eyes were prospectively randomized to receive a poly(methyl methacrylate) (PMMA), silicone, or AcrySof IOL. All lenses had 6.0 mm optics and PMMA haptics. A standardized surgical protocol was performed by a single surgeon using an extracapsular technique with capsulorhexis. Patients having surgical complications were excluded and all patients had standardized medication and follow-up. Posterior capsule opacification was assessed by a digital retroillumination camera using a dedicated software program based on the analysis of texture in the image and calculated as the percentage area of opacified capsule. Data were analyzed 2 years postoperatively.
RESULTS: There was a significant difference in percentage of PCO at 2 years among the three lens types (P < .0001). The AcrySof lenses were associated with less PCO (median 11.75%) than PMMA (43.65%) and silicone (33.50%) lenses (P < .001 and P = .025, respectively). The difference between PMMA and silicone lenses was not statistically significant.
CONCLUSION: Intraocular lenses made from AcrySof were associated with a significantly reduced degree of PCO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559471     DOI: 10.1016/s0886-3350(98)80323-4

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  24 in total

1.  Intraocular lens implants. Have come a long way, but the advances are not yet available to all.

Authors:  B Allan
Journal:  BMJ       Date:  2000-01-08

2.  Anterior capsule contraction and intraocular lens decentration and tilt after hydrogel lens implantation.

Authors:  K Hayashi; H Hayashi; F Nakao; F Hayashi
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

3.  Influence of glistenings on the optical quality of acrylic foldable intraocular lens.

Authors:  T Oshika; Y Shiokawa; S Amano; K Mitomo
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

4.  Systems of analysis of posterior capsule opacification.

Authors:  T M Aslam; B Dhillon; N Werghi; A Taguri; A Wadood
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

5.  [Influence of intraocular lens material and design on the development of posterior capsule opacification].

Authors:  O Nishi
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

Review 6.  [New methods for the prevention of posterior capsule opacification].

Authors:  G U Auffarth; T M Rabsilber; A J Reuland
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

7.  Nd:YAG capsulotomy rates after use of the AcrySof acrylic three piece and one piece intraocular lenses.

Authors:  S I Mian; K Fahim; A Marcovitch; H Gada; D C Musch; A Sugar
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

8.  Decreased visual function due to high-level light scattering in a hydrophobic acrylic intraocular lens.

Authors:  Shinichiro Yoshida; Hiroyuki Matsushima; Mayumi Nagata; Tadashi Senoo; Ichiro Ota; Kensaku Miyake
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

9.  The Auckland Cataract Study: 2 year postoperative assessment of aspects of clinical, visual, corneal topographic and satisfaction outcomes.

Authors:  A M Thompson; N Sachdev; T Wong; A F Riley; C N Grupcheva; C N McGhee
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

10.  Findings of an experimental study in a rabbit model on posterior capsule opacification after implantation of hydrophobic acrylic and hydrophilic acrylic intraocular lenses.

Authors:  Nikolaos Trakos; Elli Ioachim; Elena Tsanou; Miltiadis Aspiotis; Konstantinos Psilas; Chris Kalogeropoulos
Journal:  Clin Ophthalmol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.